Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Monday, August 20, 2012
Blocking of hepatitis B website raises ire
The sudden closure of Gandanxiangzhao, a BBS where hepatitis carriers can communicate freely, has sparked fury among hepatitis carriers and public health NGOs.